Stay updated on PEMSYS: Pembrolizumab Modulation Clinical Trial
Sign up to get notified when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.

Latest updates to the PEMSYS: Pembrolizumab Modulation Clinical Trial page
- Check4 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference1%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check68 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check83 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes a specific study focus on metastatic melanoma patients naive to immune therapy, while some detailed eligibility criteria and study descriptions have been removed.SummaryDifference42%
Stay in the know with updates to PEMSYS: Pembrolizumab Modulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.